Quantifying Inflammation Using Interleukin-6 for Improved Phenotyping and Risk Stratification in Acute Heart Failure

Abstract

An unexpectedly high percentage of patients with AHF have subclinical systemic inflammation as quantified by interleukin-6, which seems to contribute to AHF phenotype and to the risk of death.